Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4553 reports available
All reports
Page 18 of 190
June Toshin Flows Household Outward Investment Accelerates Focus On July
Bank of America · Jul 1, 2026
Early Morning Reid: June and Q2 2026 Performance Review
Deutsche Bank · Jul 1, 2026
Quarterly Updates
UniCredit · Jul 1, 2026
Daily Europe
UBS · Jul 1, 2026
International Market Intelligence Morning Briefing
J.P. Morgan · Jul 1, 2026
Why The Rotation Into Health Care May Have Room To Run
UBS · Jul 1, 2026
Europe Equity Research Today's Morning Meeting
J.P. Morgan · Jul 1, 2026
Nordic Alert
SEB · Jul 1, 2026
From Innovation to Productivity Boom Lessons from the ICT Revolution for the AI Era
Goldman Sachs · Jul 1, 2026
Federal Financing Needs Restrain Warsh
GlobalData TS Lombard · Jul 1, 2026
Asml Holding Update
Goldman Sachs · Jul 1, 2026
The Cigna Group: AI Investment in Accredo Specialty Pharmacy
Goldman Sachs · Jul 1, 2026
Positioning Intelligence Tactical Takes Health Care Upside Potential in 3Q
J.P. Morgan · Jul 1, 2026
Inside Commodities
London Stock Exchange Group (LSEG) · Jul 1, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · Jul 1, 2026
Buttonwood to Bretton Woods: 250 Years of US Innovation
UBS Financial Services Inc. · Jul 1, 2026
Daily US
UBS · Jul 1, 2026
The USMCA and Its Implications for the CAD and MXN
UBS · Jul 1, 2026
The Broadening AI Opportunity: Implications for SaaS and Private Markets
UBS · Jul 1, 2026
At the Edge of the Developer Ecosystem: Observations in and Around Vercel Ship
Goldman Sachs · Jul 1, 2026
US Conviction List Directors Cut July 2026 Spotlight
Goldman Sachs · Jul 1, 2026
Trade of the Week BAWAG
UBS · Jul 1, 2026
GS Sustain Notes From The Road
Goldman Sachs · Jul 1, 2026
New Zealand Morning Focus
ANZ · Jul 1, 2026